These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8149355)

  • 41. Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress.
    Wersinger C; Prou D; Vernier P; Sidhu A
    FASEB J; 2003 Nov; 17(14):2151-3. PubMed ID: 12958153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
    Lin Z; Itokawa M; Uhl GR
    FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.
    Zahniser NR; Larson GA; Gerhardt GA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):266-77. PubMed ID: 10087014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cocaine self-administration in dopamine-transporter knockout mice.
    Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
    Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system.
    Joyce JN; Yoshimoto K; Ueda S
    Neuroreport; 2000 Jul; 11(10):2173-5. PubMed ID: 10923665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
    Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter.
    Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS
    Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development.
    Rothman RB; Mele A; Reid AA; Akunne H; Greig N; Thurkauf A; Rice KC; Pert A
    FEBS Lett; 1989 Nov; 257(2):341-4. PubMed ID: 2583282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cocaine and 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter.
    Carroll FI; Kotian P; Dehghani A; Gray JL; Kuzemko MA; Parham KA; Abraham P; Lewin AH; Boja JW; Kuhar MJ
    J Med Chem; 1995 Jan; 38(2):379-88. PubMed ID: 7830281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and regulation of the human dopamine transporter in a neuronal cell line.
    Zhang L; Elmer LW; Little KY
    Brain Res Mol Brain Res; 1998 Aug; 59(1):66-73. PubMed ID: 9729282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
    Doolen S; Zahniser NR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
    Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
    J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
    Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter.
    Lee SH; Rhee J; Koh JK; Lee YS
    Neurosci Lett; 1996 Aug; 214(2-3):199-201. PubMed ID: 8878118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules.
    Dutta AK; Davis MC; Fei XS; Beardsley PM; Cook CD; Reith ME
    J Med Chem; 2002 Jan; 45(3):654-62. PubMed ID: 11806716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter.
    Blough BE; Keverline KI; Nie Z; Navarro H; Kuhar MJ; Carroll FI
    J Med Chem; 2002 Aug; 45(18):4029-37. PubMed ID: 12190324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
    Dutta AK; Xu C; Reith ME
    J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter.
    Vrindavanam NS; Arnaud P; Ma JX; Altman-Hamamdzic S; Parratto NP; Sallee FR
    Neurosci Lett; 1996 Sep; 216(2):133-6. PubMed ID: 8904801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.